Skip to main content
. Author manuscript; available in PMC: 2017 Mar 1.
Published in final edited form as: J Cyst Fibros. 2015 Dec 17;15(2):196–203. doi: 10.1016/j.jcf.2015.11.005

Table 4.

Multivariate analysis - Insurance status as a predictor of non-referral for lung transplant evaluation, adjusted for all covariates listed in the table

Models
Primary SES Indicator OR (95% CI) P Value

 Medicaid 1.79 (1.29, 2.47) <0.001
 No Medicaid REF
Demographics
 Age (per 5 year increase) 1.25 (1.13, 1.39) <0.001
 Male gender 1.19 (0.86, 1.65) 0.291
 Race, white vs. non-white 0.85 (0.44, 1.66) 0.640
 Not a high school graduate 2.27 (1.42, 3.64) 0.001
Disease Severity
 FEV1 % predicted 1.01 (0.97, 1.06) 0.652
 # Acute Exacerbations 0.93 (0.87, 0.99) 0.031
 Supplemental oxygen 0.59 (0.43, 0.81) 0.001
 BMI 0.95 (0.90, 1.00) 0.067
 CF-related diabetes on insulin 0.87 (0.62, 1.20) 0.390
Potential Contraindications
 Positive sputum culture:
  Burkholderia cepacia complex 2.48 (1.50, 4.12) <0.001
  Nontuberculous mycobacterium 0.69 (0.18, 2.64) 0.590
 CF-related liver cirrhosis 0.80 (0.39, 1.64) 0.538
 Renal failure requiring dialysis 0.24 (0.04, 1.38) 0.111
 Osteoporosis 0.78 (0.51, 1.20) 0.257
 Cancer, tissue proven 1.02 (0.08, 13.82) 0.987
 Depression 1.41 (0.98, 2.03) 0.065
 No marital partner 1.36 (1.00, 1.87) 0.053
 <4 outpatient visits per year 1.33 (0.90, 1.95) 0.152
Driving time to Lung Transplant Center
  <30 min (1st quartile) REF
  30–75 min (2nd quartile) 0.96 (0.60, 1.54) 0.878
  75–150 min (3rd quartile) 0.99 (0.65, 1.50) 0.947
  >150 min (4th quartile) 1.23 (0.81, 1.86) 0.343
Period of Lung Transplant
  Pre-LAS (<2005) 0.87 (0.65, 1.16) 0.332

All models adjusted for cluster effects at the level of the CF care center

OR = odds ratio, SES = socioeconomic status, FEV1 = forced expiratory volume in 1 second, BMI = body mass index, CF = cystic fibrosis, min = minutes, LAS = lung allocation score